In the original publication of the article, the eighth and ninth co-author’s affiliations were published incorrectly. The correct affiliations of the co-authors are given in this erratum.
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (Breast Cancer Research and Treatment, (2017), 163, 2, (295-302), 10.1007/s10549-017-4191-y) / Dieci, M.V., Frassoldati, A., Generali, D., Bisagni, G., Piacentini, F., Cavanna, L., Cagossi, K., Puglisi, F., Michelotti, A., Berardi, R., Banna, G., Goubar, A., Ficarra, G., Griguolo, G., Conte, P., Guarneri, V.. - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - 163:3(2017), pp. 637-637. [10.1007/s10549-017-4219-3]
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (Breast Cancer Research and Treatment, (2017), 163, 2, (295-302), 10.1007/s10549-017-4191-y)
Dieci M. V.;Frassoldati A.;Piacentini F.;Conte P.;Guarneri V.
2017
Abstract
In the original publication of the article, the eighth and ninth co-author’s affiliations were published incorrectly. The correct affiliations of the co-authors are given in this erratum.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dieci2017_Article_ErratumToTumor-infiltratingLym.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
291.99 kB
Formato
Adobe PDF
|
291.99 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
